JP Morgan Reinstates Neutral on Amgen, Announces $270 Price Target
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Chris Schott has reinstated a Neutral rating on Amgen (NASDAQ:AMGN) and announced a price target of $270.
October 20, 2023 | 6:22 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
JP Morgan analyst reinstates Neutral rating on Amgen with a price target of $270.
The reinstatement of a Neutral rating by JP Morgan indicates that the bank sees the stock as fairly valued at current levels. The price target of $270 suggests that JP Morgan believes the stock has potential for growth. This could influence investor sentiment and potentially impact the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100